File(s) under permanent embargo
Psychosocial impact of cutaneous toxicities associated with epidermal growth factor receptor-inhibitor treatment
journal contribution
posted on 2023-05-20, 10:50 authored by White, KJ, Jessica RoydhouseJessica Roydhouse, Scott, KEpidermal growth factor receptor inhibitors (EGFRIs) are an increasingly important class of anticancer agents. Cutaneous toxicities, the most common adverse effects of EGFRI therapy, require dose modification or treatment cessation when moderate or severe and may compromise treatment compliance. To date, assessment has focused on physical symptoms associated with cutaneous toxicities; however, the psychosocial impact of those effects requires greater consideration. This article reviews current knowledge of assessment of cutaneous toxicities and identifies gaps in evidence, with particular focus on the psychosocial impact of cutaneous toxicities. Promising new assessment tools and approaches including the use of electronic patient-reported outcome measures are discussed, as well as implications for research in evaluating psychosocial interventions.
History
Publication title
Clinical Journal of Oncology NursingVolume
15Pagination
88-96ISSN
1092-1095Department/School
Menzies Institute for Medical ResearchPublisher
Oncology Nursing SocietyPlace of publication
United StatesRights statement
Copyright 2011 Oncology Nursing SocietyRepository Status
- Restricted